Detalhe da pesquisa
1.
Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease.
Gastroenterol Hepatol
; 45(2): 114-122, 2022 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34023473
2.
Healthy Lifestyle Is a Protective Factor from Moderate and Severe Relapses and Steroid Use in Inflammatory Bowel Disease: A Prospective Cohort Study.
Inflamm Bowel Dis
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520736
3.
Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
Aliment Pharmacol Ther
; 59(10): 1248-1259, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445785
4.
Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease.
Nutrients
; 15(18)2023 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37764769
5.
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Aliment Pharmacol Ther
; 58(1): 60-70, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37089065